New 2021 Forecasts Released

New Data
innovation hub

CeMines is Profiled in this Database

Updated At 05 Mar, 2009

Start Free 7 Day Trial Now
Partial description of this company
Molecular FingerPrinting process for early-stage diagnosis of cancer, enabling point-of-care therapeutics based on gene regulation

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of CeMines plus 4812 other startups.

Start Free 7 Day Trial Now

Learn More About CeMines

Technology/product details

CEO presentation


Our Clients